<DOC>
	<DOC>NCT00943371</DOC>
	<brief_summary>A single dose study to assess the safety, tolerability, pharmacokinetics and pharmacokinetics of MK6349 in Type 2 Diabetics.</brief_summary>
	<brief_title>A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Subject is a nonsmoking male or female (females must be postmenopausal, had a tubal ligation or a hysterectomy) between 18 to 55 years of age Subject has Type 2 Diabetes and is currently being treated with diet and exercise alone or with less than 3 oral diabetes drugs Subject is on insulin or a PPAR agonist medication Subject has Type 1 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>